Clinical trials
Communicable Diseases trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Essen | 2 |
| Charite University, Berlin, Germany | 1 |
| CytoSorbents, Inc | 1 |
| Danone Global Research & Innovation Center | 1 |
| Enanta Pharmaceuticals, Inc | 1 |
| Erasmus Medical Center | 1 |
| Goethe University | 1 |
| Helmholtz Centre for Infection Research | 1 |
| Janssen Research & Development, LLC | 1 |
| Research Center Borstel | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Communicable Diseases | 17 |
| Pancreatitis | 2 |
| Shock, Cardiogenic | 2 |
| Acute Coronary Syndrome | 1 |
| Acute-On-Chronic Liver Failure | 1 |
| Bronchitis | 1 |
| Burns | 1 |
| COVID-19 | 1 |
| Cardiovascular Diseases | 1 |
| Chikungunya Fever | 1 |
Trials
Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.